Skip to content

Sartorius Accessia Pharma

Active
Public limited companyfounded 2016active for 10 yearsAvenue du Parc Industriel 89, 4041 Herstal, BelgiumKBO/BCE: BE 0650.670.852
Summary

The computed 12-month bankruptcy probability of Sartorius Accessia Pharma is 1.8% (moderate). The 2025 annual accounts show negative equity (-€2.0m) and a net result of €167,732. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 530 sector peers (NACE 77, financial year 2025). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Renting and leasing of other machinery, equipment and tangible goods
NACE 77399Renting and operating of own or leased non-residential real estate, excluding land NACE 68203
1 site
Size
€2.2mturnover 2025
Staff
4.8 FTE
Equity
-€2.0m
Profit
€167,732
Financial health
54 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.8%
Structure
Parent
Sartorius Xpress Biologics · 100%
Accounts 109 days early0 of 14 deeds read
Why 54raises riskNegative equity -€2.0mLiquidity: current ratio 0.04, cash €0, halvedlowers riskSize: turnover €2.2m, 4.8 FTE, total assets €5.6mFounded in 2016Show the evidence

Checked score

Score 2025
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 42% of its sector peers (NACE 77, micro)
Financial strength · tick = 2024
Weak
Solvency 0=
equity -34.8% of total assets
Liquidity 49+7
short-term debt 10.9% · cash 0.0%
Profitability 64+5
return on assets 3.0%
Bankruptcy probability, 12 months
1.8% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.5% (3,164 companies, NACE 77, micro)
Last 24 months 11-2024: 3.6% 12-2024: 3.6%● unchanged vs 11-2024 01-2025: 3.6%● unchanged vs 12-2024 02-2025: 3.7%▲ +0.1 percentage points vs 01-2025highest value 03-2025: 3.7%● unchanged vs 02-2025 04-2025: 3.7%● unchanged vs 03-2025 05-2025: 2.2%▼ -1.5 percentage points vs 04-2025 06-2025: 2.2%● unchanged vs 05-2025 07-2025: 2.2%● unchanged vs 06-2025 08-2025: 2.2%● unchanged vs 07-2025 09-2025: 2.1%▼ -0.1 percentage points vs 08-2025 10-2025: 2.1%● unchanged vs 09-2025 11-2025: 2.1%● unchanged vs 10-2025 12-2025: 2.1%● unchanged vs 11-2025 01-2026: 2.1%● unchanged vs 12-2025 02-2026: 2.2%▲ +0.1 percentage points vs 01-2026 03-2026: 2.1%▼ -0.1 percentage points vs 02-2026 04-2026: 2.2%▲ +0.1 percentage points vs 03-2026 05-2026: 2.1%▼ -0.1 percentage points vs 04-2026 06-2026: 2.0%▼ -0.1 percentage points vs 05-2026 07-2026: 2.0%● unchanged vs 06-2026 08-2026: 2.0%● unchanged vs 07-2026 09-2026: 1.8%▼ -0.2 percentage points vs 08-2026lowest value 10-2026: 1.8%● unchanged vs 09-2026lowest value
No credit on open account
Liquidity insufficient (current ratio 0.04, compared with 0.29 in 2024, below 1; short-term debt: 10.9% and cash: 0% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 77, micro): better than 7% on solvency, 54% on liquidity, 41% on profitability and 64% on growth.

The bankruptcy probability was computed on 12-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Negative equity -€2.0m
NBB · annual accounts
raises risk · Liquidity: current ratio 0.04, cash €0, halved
NBB · annual accounts
lowers risk · Size: turnover €2.2m, 4.8 FTE, total assets €5.6m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 2016
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 530 sector peers (2025).
NBB · sector comparison
Position among 530 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-04-2026, 109 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
109 days early
2024
113 days early
2023
63 days early
2022
66 days early
2021
10 days late
2020
110 days early
2019
37 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 70 days before the deadline; the sector median (NACE 77) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 May (4 of the last 5 filed years within 47 days of that day).
Companies Code · seven months
Where today falls in the filing period
13-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Highest result from 2018 to 2025net €167,732 ▲339%
  3. Annual accounts filedfinancial year 2024 · full…

Key points

  • Risk: Negative equityfinancial year 2025: debts exceed assets -€2.0m View
  • Positive: Result rose in 2025from €38,218 to €167,732 ▲ 339% View
  • Caution: Among the weakest 5% on solvencysector median 41.5% · 530 companies -34.8% View
  • Positive: 4 years of growth in a rowturnover 2025: €2.2m 4 years View
  • Controlled by Sartorius Xpress Biologicsultimately: Sartorius AG 100% View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Turnover
€2.2m
Profit
€167,732
Solvency
-34.8%
Turnover▲ 8.1%
Net result
20182025
Go to Financials

Timeline

Events
13
Since
2018
Next accounts
by 31-07-2027
  1. 31-12-2024Back to profit
  2. 29-05-2024Annual accounts filed
  3. 26-05-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Renting and leasing of other machinery, equipment and…NACE 77399
Founded
22-03-2016
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.